Eurocare 5 Survival Analysis 2000 - 2007

Cancer Site

lip skin melanoma
tongue breast
oral cavity Cervix Uteri
Salivary Gland corpus uteri
oropharynx ovary
nasopharynx vagina and vulva
hypopharynx prostate
head and neck testis
esophagus penis
stomach urinary bladder
small intestine kidney
Colon Rectum brain
colon thyroid
rectum Plasma cell
Liver Hodgkin's lymphoma
Gallbladder non hodgkin lymphoma
pancreas SBLL/CLL
nasal cavities LL/ALL
larynx AML
Lung MPN
pleura CML
Bones and cartilages MDS
soft tissue all sites

Cancer entities included in EUROCARE-5

Population

Denmark Central Europe

Finland CROATIA
Iceland Italy
Norway Malta
Sweden Portugal
Northern Europe Slovenia
Ireland Spain

UK England Southern Europe

UK Northern Ireland BULGARIA
UK Scotland Czech Republic
UK Wales ESTONIA
UK and Ireland LATVIA
Austria LITHUANIA
Belgium Poland
France SLOVAKIA

Germany Eastern Europe

Switzerland Pool of European CRs
Netherlands European average

List of cancer registries included in analyses

Age Class

15-44
15-54
45-54
55-64
65-74
75-84
75+
85+
15+
ICSS standard

ICSS - International Cancer Survival Standards

Time from diagnosis

0 yr
<1 yr
1-<2 yr
2-<3 yr
3-<4 yr
4-<5 yr

Sex

Men
Women
Men & Women

Period of Diagnosis

2000 - 2007

Output Indicators

Alive at Start Observed Survival, Cum (OSC) Relative Survival, Cum (RSC) Relative SE's, Cum (RSEC)
Dead Expected Survival, Interval (ESI) Observed SE's, Interval (OSEI) RSC: Lower bound
Lost to Follow Up Expected Survival, Cum (ESC) Observed SE's, Cum (OSEC) RSC: Upper bound
Observed Survival, Interval (OSI) Relative Survival, Interval (RSI) Relative SE's, Interval (RSEI)